Search result

Phantom 4 RTK/feed/category/dji-mavic-3-pl- Page 161

Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands shares traded near $10.53 on December 24, 2025, following sharp gains in the second half of the year. President Donald Trump signed an executive order on December 18 to begin the process of reclassifying marijuana from Schedule I to Schedule III. The move sparked volatility across cannabis stocks, with prices swinging as investors weighed the potential impact. The order does not legalize cannabis but directs federal agencies to review its status.
Palantir (PLTR) Stock News Today, Dec. 24, 2025: Price Action, Fresh AI Contract Catalysts, and 2026 Forecasts

Palantir (PLTR) Stock News Today, Dec. 24, 2025: Price Action, Fresh AI Contract Catalysts, and 2026 Forecasts

Palantir Technologies shares traded near $193.84 on Dec. 24, 2025, after rebounding from a post-earnings drop earlier in the year. The stock remains volatile, hovering below the $200 mark as investors weigh strong AI contract momentum against concerns over high valuations. Retail demand and index inclusion have fueled trading activity. Technical analysts cite resistance near $194 and support around $150.
Opendoor Technologies (OPEN) Stock News and Forecasts for Dec. 24, 2025: Mortgage Expansion, AI Pivot, and Analyst Targets

Opendoor Technologies (OPEN) Stock News and Forecasts for Dec. 24, 2025: Mortgage Expansion, AI Pivot, and Analyst Targets

Opendoor Technologies traded around $6.16 in a quiet Dec. 24, 2025 session after announcing the acquisition of Homebuyer.com and naming its founder Dan Green as Director of Mortgage Growth. The company signaled plans to accelerate iBuying and expand mortgage offerings, while investors weighed the impact of ongoing leadership changes and a challenging U.S. housing market.
Pfizer Stock (PFE) on Dec. 24, 2025: Latest News, 2026 Guidance, Dividend, and Analyst Forecasts

Pfizer Stock (PFE) on Dec. 24, 2025: Latest News, 2026 Guidance, Dividend, and Analyst Forecasts

Pfizer shares traded near $24.93 in thin holiday trading Dec. 24 after the company reported a patient death in a long-term study of its hemophilia drug Hympavzi. The company said it does not expect the event to alter the drug’s safety profile. U.S. policy moves to lower drug costs also weighed on sentiment. Pfizer reaffirmed 2025 earnings guidance and issued conservative 2026 forecasts.
24 Dezembro 2025
Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla shares traded around $485 on Dec. 24, just below the $500 mark after hitting a record high of $498.83 last week. The U.S. NHTSA opened a defect probe into 179,071 Model 3 vehicles over emergency door release concerns. Wall Street analysts trimmed delivery forecasts, citing pressure on core EV sales. Trading volume was lighter due to the holiday-shortened session.
Rivian Stock (RIVN) News on Dec. 24, 2025: Analysts Split on 2026 Upside as R2 and Autonomy+ Take Center Stage

Rivian Stock (RIVN) News on Dec. 24, 2025: Analysts Split on 2026 Upside as R2 and Autonomy+ Take Center Stage

Rivian shares traded near $21.22 on Dec. 24, 2025, as investors weighed the company’s push to rebrand as a software-driven vehicle platform. Analysts cited Rivian’s custom self-driving chip, developed with TSMC, and the upcoming R2 model as key catalysts. Price targets remain divided despite a recent rally. Rivian’s new Autonomy+ subscription undercuts Tesla’s pricing, aiming for recurring revenue.
Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

Rocket Lab shares slipped modestly on December 24, trading in the mid-$70s after a sharp December rally driven by an $816 million U.S. Space Development Agency contract for 18 satellites. The pullback came during a low-volume, early-close session on Christmas Eve. U.S. equity markets closed at 1 p.m. ET, with normal trading resuming after Christmas. Rocket Lab’s total SDA contract value now exceeds $1.3 billion.
Visa Stock News Today (NYSE: V): $500M Litigation Escrow Move, Holiday Spending Read-Through, and Analyst Forecasts for 2026

Visa Stock News Today (NYSE: V): $500M Litigation Escrow Move, Holiday Spending Read-Through, and Analyst Forecasts for 2026

Visa shares rose 0.62% to $355.57 in a shortened Christmas Eve session after the company disclosed a $500 million deposit into a litigation escrow tied to its retrospective responsibility plan. The move, detailed in a December 23 SEC filing, alters the conversion rate of certain Visa shares, affecting earnings per share similarly to a buyback. Trading volume reached about 781,600 shares by late morning.
24 Dezembro 2025
Intel Stock INTC Slips as Nvidia Pauses 18A Test: Latest News, Forecasts, and What Matters Next

Intel Stock INTC Slips as Nvidia Pauses 18A Test: Latest News, Forecasts, and What Matters Next

Intel shares fell about 1% to $35.97 on December 24 after reports that Nvidia halted testing of Intel’s 18A chip manufacturing process. Trading was light in a shortened Christmas Eve session. Intel said its 18A technology is progressing and highlighted ongoing interest in its next-generation 14A process. The U.S. government recently announced an $8.9 billion equity investment in Intel.
24 Dezembro 2025
BETA Technologies Stock (NYSE: BETA) on Dec. 24, 2025: Latest News, Earnings Outlook, and Analyst Forecasts

BETA Technologies Stock (NYSE: BETA) on Dec. 24, 2025: Latest News, Earnings Outlook, and Analyst Forecasts

BETA Technologies shares closed at $30.12 on Dec. 24, 2025, down 4.7% in thin holiday trading. The stock, which debuted on the NYSE in early November at $34 per share, is now about 11% below its IPO price. Market capitalization stands near $7 billion. No major company news drove the decline; analysts cited post-IPO volatility and low volume.
Treasury Wine Estates (ASX:TWE) Stock News: Share Price Rebound, “TWE Ascent” Reset, and What Analysts Forecast Heading Into 2026

Treasury Wine Estates (ASX:TWE) Stock News: Share Price Rebound, “TWE Ascent” Reset, and What Analysts Forecast Heading Into 2026

Treasury Wine Estates cut its 1H26 EBITS outlook to A$225m–A$235m on Dec. 17, citing weak U.S. and China demand and channel disruption. Shares closed at A$5.390 on Dec. 25, down sharply from the year’s high. Management withdrew FY26 guidance in October and flagged a major U.S. impairment in December. Analysts slashed forecasts after the company warned near-term recovery is unlikely.
25 Dezembro 2025
Singapore Exchange Ltd (SGX: S68) Stock: Latest News, Dividend Outlook, and Analyst Forecasts as of 25 Dec 2025

Singapore Exchange Ltd (SGX: S68) Stock: Latest News, Dividend Outlook, and Analyst Forecasts as of 25 Dec 2025

Singapore Exchange shares closed at S$17.26 on 24 December 2025, near multi-year highs. November securities market turnover rose 18% year-on-year to S$35.5 billion, with daily average value up 24%. The Straits Times Index hit a record 4,575.91. SGX launched institutional-only Bitcoin and Ethereum perpetual futures in November.
Castrol India Stock in Focus on 25 Dec 2025: Open Offer at ₹194.04 After BP Sells Castrol Stake to Stonepeak

Castrol India Stock in Focus on 25 Dec 2025: Open Offer at ₹194.04 After BP Sells Castrol Stake to Stonepeak

BP agreed to sell a 65% stake in Castrol to Stonepeak for $10.1 billion, triggering a mandatory open offer for up to 26% of Castrol India at ₹194.04 per share. CPP Investments will invest up to $1.05 billion for an indirect stake. Castrol India shares jumped 9% to ₹202.40 on December 24 after the news. The transaction is expected to close by end-2026, pending regulatory approvals.
Shops Open on Christmas Day in the UAE 2025: Dubai & Abu Dhabi Mall Hours, Supermarkets, Pharmacies and Last-Minute Essentials

Shops Open on Christmas Day in the UAE 2025: Dubai & Abu Dhabi Mall Hours, Supermarkets, Pharmacies and Last-Minute Essentials

Most malls and supermarkets in the UAE remain open on Christmas Day, as December 25 is not an official public holiday. Dubai Mall operates from 10 a.m. to 11 p.m., with supermarkets and pharmacies open as early as 7 a.m. and until 1 a.m. Mall of the Emirates and Dubai Festival City Mall also maintain regular hours, with hypermarkets opening at 8 a.m.
25 Dezembro 2025
Shops Open on Christmas Day in South Africa: 2025 Trading Hours, Malls, Supermarkets and What to Expect Today

Shops Open on Christmas Day in South Africa: 2025 Trading Hours, Malls, Supermarkets and What to Expect Today

Many South African malls are open on Christmas Day, but most stores choose whether to trade and set their own hours. Notices from major centres including Sandton City, Mall of Africa, and Canal Walk confirm “optional” or “voluntary” trading on 25 December 2025. Shoppers report only select supermarkets, food outlets, and restaurants operating. Customers are urged to check store hours before visiting.
25 Dezembro 2025
1 159 160 161 162 163 176

Stock Market Today

  • Australian ASX set to rise as Wall Street tech rally boosts markets; Bitcoin recovers above $70,000
    February 8, 2026, 3:26 PM EST. The U.S. stock market surged Friday with the S&P 500 rising 2% and the Dow hitting 50,000 points for the first time, driven by gains in technology and chip stocks like Nvidia and Broadcom. Their rally was fueled by investor optimism about artificial intelligence (AI) investments, despite concerns over the profitability of massive spending by tech giants such as Amazon and Alphabet. Amazon's shares dropped 5.6% after revealing plans for $285 billion in investments. The Australian sharemarket (ASX) is positioned to open 1.2% higher following its 2% drop on Friday. Bitcoin rebounded past $70,000 after recovering from a sharp decline below $60,000. Precious metals also steadied, with gold up 1.8% and silver rising 0.2%, as investors sought safe havens amid market uncertainties.

Latest article

Popular

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Ações da Adaptimmune Therapeutics (ADAP) Disparam 42% – Será Esta a Virada Real Desta Biotech?

9 Outubro 2025
Terapia (Alvo) Indicação Status (2025) Propriedade Atual TECELRA(afamitresgene, alvo MAGE-A4) Sarcoma sinovial (irressecável/metastático) Aprovado pela FDA ago 2024biospace.com; ~16 pacientes tratados no ano de lançamentonasdaq.com. Vendido para US WorldMeds (2025)adaptimmune.com Letetresgene (lete-cel, NY-ESO-1) MRCLS e sarcoma sinovial (tumores sólidos avançados) Fase II concluída (taxa de resposta de 42%)stocktitan.net; Designação de Breakthrough da FDA em 2025stocktitan.net; submissão de BLA planejada para 2025. Vendido para US WorldMeds (2025)adaptimmune.com Uzatresegene (uza-cel, TCR de próxima geração) Tumores sólidos (TCR MAGE-A4, em parceria com Galapagos) Estágio pré-clínico/viabilização de IND; acordo de parceria US$ 665M assinado em 2024fiercebiotech.com. Vendido para US WorldMeds (2025)adaptimmune.com TCR direcionado a
Go toTop